Abortion
Assisted Reproduction in a Post-Dobbs US
Assisted reproductive technologies face an uncertain future as anti-abortion policymakers work to restrict access to reproductive care post-Dobbs.
Assisted Reproduction in a Post-Dobbs US
Author
Chloe Reichel
-
-
Bioethics
Bill of Health’s Top 10 Posts of 2022
The top ten most-read articles published on Bill of Health in 2022.
Bill of Health’s Top 10 Posts of 2022
-
Blog Symposia
The Impossibility of Legal Accountability for COVID-19 Torts
Torts scholars reflect on questions surrounding whether and how entities might be held liable for the harms associated with SARS-CoV-2 infection.
The Impossibility of Legal Accountability for COVID-19 Torts
-
Bioethics
Introduction to the Symposium: Health Law and Policy in an Era of Mass Suffering
In this symposium, our hope is to acknowledge — and mourn — this current era of mass suffering and death.
Introduction to the Symposium: Health Law and Policy in an Era of Mass Suffering
-
Abortion
The Leaked Dobbs Opinion, Explained
The background of the case, the contents of the draft opinion, and potential implications for abortion access and other rights.
The Leaked Dobbs Opinion, Explained
-
Bioethics
Introduction to the Symposium: Build Back Better? Health, Disability, and the Future of Work Post-COVID
This symposium aims to address the critical junctures of health, disability, and work at the heart of the domestic policy response to COVID-19.
Introduction to the Symposium: Build Back Better? Health, Disability, and the Future of Work Post-COVID
-
Bioethics
Please Keep Your Masks On
Wearing masks in common, indoor spaces is such a small, easy, powerful act to help prevent the spread of disease.
Please Keep Your Masks On
-
Bioethics
COVID-19 is Still a Crisis for All
We need to understand: We can’t end this pandemic with vaccines alone.
COVID-19 is Still a Crisis for All
-
aging
FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.
FDA Approves Aducanumab for Alzheimer’s Disease: An Unethical Decision?
-
Antitrust
To Cut Prescription Drug Spending, Stop Delays for Generic Competition
While generic competition is crucial for reducing drug prices, brand-name drug manufacturers can utilize several strategies to delay such competition.
To Cut Prescription Drug Spending, Stop Delays for Generic Competition
